Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention - Wikidata - wikimedia - TriplyDB

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

http://www.wikidata.org/entity/Q28391736

about

Soluble epoxide hydrolase: gene structure, expression and deletion Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ Soluble epoxide hydrolase in atherosclerosis

P2860

Q28291292-3000CE4B-07F0-4FD6-9E5E-C5458F75B2A1 Q28392991-CCF33A58-A64F-4DBD-815E-E9CB4160FFAA Q28395004-1C5C89FD-D19C-4435-B9A5-7E41BA135460

P2860

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

http://www.wikidata.org/entity/Q28391736

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Variation in the human soluble ...... utaneous coronary intervention

@ast

Variation in the human soluble ...... utaneous coronary intervention

@en

Variation in the human soluble ...... utaneous coronary intervention

@nl

type

label

Variation in the human soluble ...... utaneous coronary intervention

@ast

Variation in the human soluble ...... utaneous coronary intervention

@en

Variation in the human soluble ...... utaneous coronary intervention

@nl

prefLabel

Variation in the human soluble ...... utaneous coronary intervention

@ast

Variation in the human soluble ...... utaneous coronary intervention

@en

Variation in the human soluble ...... utaneous coronary intervention

@nl

P1433

Q28391736-D4CA5123-3C24-4216-82B0-48EEC5F4CE0C

P1476

Q28391736-DA671E02-78EF-4EB9-9C6B-BEC3558D204E

P2093

Q28391736-10BD1939-6172-493C-BEEC-DEFBC64153B1

Q28391736-275D6BD7-3442-49D7-8B40-9B1168CE97A7

Q28391736-3583A913-38A4-45AE-A8D8-B797B4C75424

Q28391736-4AA44D73-3B9B-4232-A767-F598BAB7BD20

Q28391736-698AD0FB-A9E4-4160-A0E1-052CE7D1B6B4

Q28391736-90D0E0EF-3EDF-41EB-B99E-7F75382DE8D9

Q28391736-A5302E24-30FC-491C-A158-227414471BF9

Q28391736-D2064BC5-4ABD-46C9-8AA0-65C845673847

Q28391736-F415601A-05A6-4151-B9D8-55AEB2A9765F

Q28391736-F6A0CA2D-5BCB-40A1-8BA5-50E840E758AB

P2860

Q28391736-05A5EB86-805C-40F5-BA4C-060C1ED8D57D

Q28391736-08D4379E-BABA-4A0C-A578-1D039661EFF0

Q28391736-0AD3981D-66C7-4B20-8933-D449EF6BED40

Q28391736-1F24CD06-AF17-40AA-AAAF-89B95D6CDEB1

Q28391736-49D002FD-3C17-42E0-8C4D-4F403BB3F659

Q28391736-4A0FFE4B-97D8-4D64-BBEE-2842F8D32B90

Q28391736-579D7C1D-6A5B-429D-9F70-E4CF9D52DECA

Q28391736-5A8BDB5D-3FD8-48D4-99BD-0D67D126A25C

Q28391736-61D74B6C-8F99-4592-8ACB-3187B1786108

Q28391736-63101412-3F01-4E87-9385-1ADDB7012A5E

P2888

Q28391736-39B3B45B-93B8-49D2-9885-2CA80B86C06B

P304

Q28391736-D195EB58-18F6-496E-97BA-70A29881183E

P31

Q28391736-368B859A-451F-4DEF-97A2-E83073E23C12

P356

Q28391736-5E85787B-54DF-4456-BE1F-E00895E87386

P407

Q28391736-CA1D7631-7E92-4F79-B9C5-E78D236BC208

P433

Q28391736-B988CCD3-EE95-41D4-9DB0-00B422DBEBC4

P478

Q28391736-1ABC2521-4AAF-4A19-A57B-5B292B41141A

P577

Q28391736-97FC462C-0F04-41F6-87B3-9A6420D911B1

P5875

Q28391736-E3EDE119-64EA-42D4-8D41-B6014B11FD97

P6179

Q28391736-6E9A8611-6E74-42C4-A264-3A2A8B5853A3

P698

Q28391736-38B97C6A-68C1-4C2F-9805-4D0153FE8F2D

P932

Q28391736-07E66093-6E6B-4B93-B9B0-3A98F01DFBC2

P356

P1433

BMC Cardiovascular Disorders

P1476

Variation in the human soluble ...... utaneous coronary intervention

@en

P2093

Andreas Huge

http://www.w3.org/2001/XMLSchema#string

Eberhard von Hodenberg

http://www.w3.org/2001/XMLSchema#string

Georg Haltern

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Bestehorn

http://www.w3.org/2001/XMLSchema#string

Kirsten Rackebrandt

http://www.w3.org/2001/XMLSchema#string

Mark Lankisch

http://www.w3.org/2001/XMLSchema#string

Priska Binner

http://www.w3.org/2001/XMLSchema#string

Reiner Füth

http://www.w3.org/2001/XMLSchema#string

Silke Kullmann

http://www.w3.org/2001/XMLSchema#string

Thomas Scheffold

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms

Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study

Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox?

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

New role for epoxyeicosatrienoic acids as anti-inflammatory mediators

Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study

P2888

P304

48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2261-9-48

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26880805

http://www.w3.org/2001/XMLSchema#string

P6179

1040343765

http://www.w3.org/2001/XMLSchema#string

P698

19814804

http://www.w3.org/2001/XMLSchema#string

P932

2767343

http://www.w3.org/2001/XMLSchema#string